KindlyMD Stock at Risk of Nasdaq Delisting Over Share Price Compliance

KindlyMD, a healthcare services company, is confronting a significant risk of being delisted from the Nasdaq Capital Market. The company received a formal notification from Nasdaq due to its failure to maintain a minimum bid price of $1.00 per share over a consecutive 30-day trading period. This non-compliance with Nasdaq Listing Rule 5550(a)(2) triggers a potential delisting process. KindlyMD now has a 180-day grace period, until October 21, 2024, to regain compliance. To meet the requirement, the company's common stock must achieve a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days before the deadline. If compliance is not achieved, KindlyMD may face delisting, though it could appeal the decision or consider transferring its listing to another market tier. The company has stated it intends to actively monitor its share price and evaluate all available options to resolve the deficiency and maintain its Nasdaq listing.